跳至主要内容
临床试验/NCT07208188
NCT07208188尚未招募1 期

Transcutaneous Spinal Cord Stimulation for Rehabilitation of Upper Limbs in Early Spinal Cord Injury: Randomised Feasibility Study

NHS Greater Glasgow and Clyde1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年11月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
尚未招募
入组人数
20
试验地点
1
主要终点
Retention

研究概览

简要总结

Regaining hand and arm function is an important step towards regaining independence following high-level spinal cord injury (tetraplegia). The delivery of small electrical pulses over the skin above the spinal cord, called transcutaneous spinal cord stimulation (tESCS), appears to improve the arm and hand function of people who have had tetraplegia for several years when delivered at the same time as upper limb therapy. However, tESCS has not been tested in people who have a new spinal cord injury. It should be straightforward to deliver tESCS during standard upper limb therapy sessions to inpatients receiving primary rehabilitation. The investigators want to test the practical aspects of delivering this intervention and also to compare recovery between a group of people who only receive upper limb therapy and a group who receive upper limb therapy and tESCS. If successful, tESCS could in the future be used as part of regular therapy following an acute spinal cord injury. Benefits could include faster and better recovery, reduced stay in hospital, and reduced NHS costs.

详细描述

Background Spinal Cord Injury affects more than 50,000 people in the UK, with an incidence of 2400 new cases every year. Muscular paralysis and sensory loss carry substantial physiological, psychological, financial, and social costs. Almost 60% of people affected by SCI sustain a high-level injury, that is, injury to spinal levels C2-T1, affecting arms and hands. Restoring hand and arm function is a top priority for people with tetraplegia, where even small improvements of motor function, combined with available assistive devices, may greatly improve independence and quality of life.

Transcutaneous spinal cord stimulation (tESCS) has emerged as a viable neuromodulation approach for facilitating the recovery of motor function in people with SCI. Studies that have applied tESCS at cervical segments combined with activity-based upper limb rehabilitation. Such active-assisted exercises such as gross and fine motor skill training, maximum voluntary contraction training, and unimanual and bimanual task performance have shown significant improvements in upper limb function.

It is believed that tESCS stimulation activates motor neuronal networks of the spinal cord, including the recruitment of afferent fibres in the posterior root, to elevate spinal network excitability. The underlying hypothesis is that after severe cervical SCI, nonfunctional sensory-motor networks within the cervical spinal cord can be transcutaneously neuromodulated to physiological states that enable and amplify voluntary control of the arm and hand.

A multicentre ONWARD Up-LIFT trial, which included 14 research sites, including QENSIU, has demonstrated functional improvements in people with incomplete chronic tetraplegia. As part of a UK Neuromodulation Network, we were awarded funding to deliver a substantial follow-up study, focusing on chronic complete tetraplegia. The results are showing some neurological recovery but modest functional improvement, indicating that some minimal level of preserved sensory or motor function is required in order to benefit from tESCS. For that reason, the investigators plan to recruit people with incomplete SCI in this study.

Rationale In the area of upper limb rehabilitation, the focus has been mainly on people with chronic SCI, likely due to the lack of alternative rehabilitation strategies and the difficulty in applying acute interventions in the clinical setting [3-8]. However, to date, there have been limited studies reporting the use of tESCS with people with subacute SCI. A randomised controlled trial with 22 complete or incomplete tetraplegic patients (3-12 months post injury, probably recruited from home) compared 8 sessions of tESCS with Armeo robot exercise to 8 sessions of Armeo alone. Both groups achieved comparable functional improvement but Armeo group had a higher change in scores. Our recent search of ClinTrials.gov (search criteria Spinal Cord Injuries, Upper extremity dysfunctions and electrical stimulation) has however, identified no current or future study which includes people with subacute SCI and randomisation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Aged 18 years or over, both sexes.
  • •At least 6 weeks post-implant (in participants having a surgery for an implant to stabilise the spine).
  • •ISNCSCI upper extremity motor score between 5 and 30 (both arms/hands)
  • •GRASSP-strength score >=15 & <70
  • •Medically stable, cognitively intact and able to breathe independently.
  • •Attending upper limb therapy sessions at the QENSIU
  • •Planned stay longer than the duration of the intervention
  • •Able to sit for more than 2 hours a day

排除标准

  • •Unstable cervical spine injury
  • •Needing ventilation assistance during daytime
  • •Any implanted active metallic device without unconfirmed MRI compatibility (in our previous studies, we safely applied tESCS to participants with MRI-compatible devices/implants)
  • •Pregnancy and/or lactation.
  • •Non-injury-related neurological impairment
  • •Severe spasticity which have been unstable prior to enrolment
  • •Botulinum toxin injections-
  • •Clinically significant severe depression
  • •Patients who have cardiovascular disease
  • •Patients with severe ongoing Autonomic Dysreflexia
  • •Skin conditions or allergies that may affect electrode placement.
  • •Current infections
  • •Patients who have been involved in any other interventional study

研究组 & 干预措施

Intervention

Experimental

One hour of transcutaneous electrical stimulation alongside conventional occupational therapy

干预措施: Transcutaneous spinal cord stimulation (tESCS) active group (Device)

Control

Sham Comparator

Receiving 1 minute of stimulation alongside the conventional occupational therapy

干预措施: Sham transcutaneous spinal cord stimulation (tESCS) (Device)

结局指标

主要结局

Retention

时间窗: From enrollment till the last assesment at 8 weeks

Recruitment and retention

Interference

时间窗: From enrolment till the end of intervention at 4 weeks

Interference with daily routine

Stimulation

时间窗: From the first till the last intervention session at 4 weeks

Optimal current stimulation intensity in mA

Adverse effects

时间窗: from the first till the last intervention session at 4 weeks

The number of adverse effects

Feedback

时间窗: From enrolment till the last assesment at 8 weeks

Semi structured interview

次要结局

  • Hand function(From the first intervention session till the last assesment at 8 weeks)
  • Spinal Cord Independence Measure(From the recruitment till the last assessment at 8 weeks)
  • Quality of life basic dataset(From recruitment till the last assessment at 8 weeks)
  • Spasticity(From the enrolment till the last assesment at 8 weeks)
  • Dynamometry(From the enrolment till the last assesment at 8 weeks)
  • International Standard for Neurological Classification of Spinal Cord Injury(From the enrolment till the last assesment at 8 weeks)
  • Motor evoked potential(From the recruitment till the last assesment at 8 weeks)
  • Somato sensory evoked potential(From the recruitment till the last assesment at 8 weeks)
  • Muscle synergy(From the recruitment till the last assesments at 8 weeks)
  • Box and Block test (the number of transferred blocks in 60s, out of 150 blocks)(From the recruitment till the last assessment at 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

tESCS for Upper Limb Rehab in Spinal Cord Injury | 临床试验